This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 19-22, 2025
Manchester Grand Hyatt San DiegoSan Diego, CA

Holly Kordasiewicz, PhD
SVP Research, Franchise Leader Neurology R&D at Ionis Pharmaceuticals
Speaker

Profile

Dr. Holly Kordasiewicz is Senior Vice President of Neurology Research at Ionis Pharmaceuticals, a company that specializes in RNA therapeutics. Dr. Kordasiewicz leads a team focused on identifying antisense oligonucleotide therapeutics for currently untreatable neurological diseases, including drugs now in clinical trials for ALS, Alzheimer’s disease, and Parkinson’s disease. Dr. Kordasiewicz joined Ionis 11 years ago after completing her post-doctoral fellowship in the laboratory of Dr. Don Cleveland at the University of California at San Diego where she worked to develop therapies for Huntington’s disease. Dr. Kordasiewicz began her work on understanding neurological diseases at the University of Minnesota, where she received her Ph.D. in Neuroscience.

Agenda Sessions

  • Antisense Oligonucleotides for the Treatment of Neurological Disease

    9:30am